Meditation and Menopausal Hot Flashes
Speaker: Susan Cohen, PhD
Format: Audio & Slides
Objective: The purpose of this randomized feasibility pilot study was to examine mindfulness meditation for menopausal symptom management.
Methods: The study was designed to explore the treatment benefit of a mindfulness meditation program for menopausal symptom relief using changes in frequency and severity of hot flushes and frequency of sleep disruption. A two group design included a meditation group and an attention control group. Participants were randomized to the attention control group were offered meditation training after completion of the intervention and follow up phases. Participants attended 8 meditation sessions or 8 attention control sessions. Study variables are Menopausal Hot Flashes (self-report), and Sleep Disruption (Pittsburgh Sleep Quality Index- PSQI). An Intention to Treat approach was used. Descriptive statistics and Analysis of Variance were used.
Results: A convenience sample of 46 women who experienced menopausal symptoms was recruited. Diary results indicated a significant time effect (p= .018; .045) for hot flashes; however there was not a group by time effect, indicating improvement in both groups. There was a time effect for sleep disruptions ( p=0.04) yet no group by time effect (p=0.48) was found to differentiate the groups. PSQI measured Global Score (p=0.03); Sleep Latency (p=0.05) and Subjective Sleep Quality (p=0.01) all showed a positive time effect. In both the meditation and education groups, a positive time effect was seen in sleep disruption and sleep dimensions measured by the PSQI.
Conclusions: In contrast to other meditation studies, participant's symptoms (hot flashes; sleep) improved in both the meditation and attention control groups. The educational attention control protocol had been used by the authors previously in a one to one format without positive influence on hot flashes or sleep disruptions. The influence of group support in the attention control group may have resulted in decreases in symptoms.
|